Table 5.
Complication | Control (n = 44) | ILD-rFVIIa (n = 44) | p Value |
---|---|---|---|
Reoperation for bleeding | 1 (2.3%) | 0 | 0.31 |
Delayed sternal closure | 2 (4.5%) | 2 (4.5%) | 1 |
Deep sternal wound infection | 0 | 0 | 1 |
New-onset arrhythmia | 15 (34.1%) | 19 (43.2%) | 0.51 |
Pacemaker placement | 3 (6.8%) | 2 (4.5%) | 0.65 |
Peak postoperative creatinine (mg/dL) | 1.4 (1.2–1.7) | 1.4 (1.1–2.0) | 0.80 |
Acute renal failure (Cr > 2.0 and > 2× baseline) | 3 (6.8%) | 5 (11.4%) | 0.46 |
New-onset dialysis | 1 (2.3%) | 1 (2.3%) | 1 |
Prolonged ventilation (> 24 hours) | 11 (25%) | 7 (15.9%) | 0.43 |
Tracheostomy | 4 (9.1%) | 0 | 0.12 |
Myocardial infarction | 0 | 1 (2.3%) | 0.31 |
Pulmonary embolism | 1 (2.3%) | 1 (2.3%) | 1 |
Mesenteric ischemia | 1 (2.3%) | 0 | 0.31 |
Any stroke (neurologic deficit lasting > 72 hours) | 3 (6.8%) | 1 (2.3%) | 0.62 |
Embolic stroke | 2 (4.5%) | 0 | 0.49 |
Permanent paraparesis/paraplegia | 1 (2.3%) | 0 | 0.31 |
Postoperative length of stay (days) | 6 (5–9) | 7 (5–11) | 0.33 |
30-day/in-hospital death | 1 (2.3%) | 1 (2.3%) | 1 |
Values expressed as median (interquartile range) or number (percent).
Cr = creatinine; ILD-rFVIIa = intraoperative low-dose recombinant activated factor VII.